Lunch Report: 25 July, 2022
Paul Sanger from Finance News Network with all the news from today’s morning trading session on the ASX.
Read More
Stocks of the Hour: 25 July, 2022
Tim McGowen from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read More
Lunch Report: 22 July, 2022
Paul Sanger from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreStocks of the Hour: 22 July, 2022
Tim McGowen from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read More
Evening Report: 21 July, 2022
Paul Sanger from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 21 July, 2022
Paul Sanger from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreStocks of the Hour: 21 July, 2022
Tim McGowen from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read MoreEvening Report: 20 July, 2022
Paul Sanger from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 20 July, 2022
Paul Sanger from Finance News Network with all the news from today’s morning trading session on the ASX.
Read More
Evening Report: 19 July, 2022
Paul Sanger from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 19 July, 2022
Paul Sanger from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreStocks of the Hour: 19 July, 2022
Tim McGowen from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read More
Stocks of the Hour: 18 July, 2022
Tim McGowen from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read MoreLunch Report: 18 July, 2022
Tim McGowen from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreEvening Report: 15 July, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreStocks of the Hour: 15 July, 2022
Melissa Darmawan from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read MoreEvening Report: 14 July, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 14 July, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreStocks of the Hour: 14 July, 2022
Melissa Darmawan from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read More
Evening Report: 13 July, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 13 July, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreStocks of the Hour: 13 July, 2022
Melissa Darmawan from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read MoreEvening Report: 12 July, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreStocks of the Hour: 12 July, 2022
Melissa Darmawan from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read MoreLunch Report: 12 July, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreLunch Report: 11 July, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreStocks of the Hour: 11 July, 2022
Melissa Darmawan from Finance News Network breaks down some stocks making noise in today’s ASX trading session.
Read MoreRadiopharm Theranostics (ASX:RAD) to start prostate cancer trial
Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company’s portfolio of therapies.
Read More
